GL1X · GenesisL1 explorer

MolNFT v1 · #37377 · protein

Human aldose reductase complexed with tolrestat at 1.08 a resolution.

2FZD: “Human aldose reductase complexed with tolrestat at 1.08 a resolution.”. X-ray diffraction, 2 ligands (NAP, TOL), 2 pockets (best druggability 0.72). MolNFT v1 #37377 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2FZD
Type
protein
Length
313 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Aldose reductase
EC
1.1.1.21
UniProt
Q5U031
Ligands
NAP, TOL
Pockets
2 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAldose reductase (EC 1.1.1.21)protein31340% helix, 15% strandQ5U031

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • TOL · Tolrestat · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13090.720.8548NAP, TOL
2570.320.7617empty

Compared structures

  • 2FZD · Human aldose reductase complexed with tolrestat at 1.08 A resolution. · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.